← Eichor · All briefs

NCT05700669 — Metastatic Castration-resistant Prostate Cancer trial site landscape

Public-registry site landscape for NCT05700669, a Metastatic Castration-resistant Prostate Cancer study sponsored by Valerio Therapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.

TrialNCT05700669 (registry record)
SponsorValerio Therapeutics
Condition(s)Metastatic Castration-resistant Prostate Cancer; Recurrent Epithelial Ovarian Cancer; Breast Cancer
PhasePHASE1 / PHASE2
Listed sites1
Site countriesUnited States

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT05700669 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.